Endovascular aneurysm treatment in patients with vasculo-Behçet disease

Journal of Endovascular Therapy

Volumn 16, Issue 5, 2009, Pages 637-

  Kasirajan, Karthik ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ANEURYSM; ARTERY BYPASS; BEHCET DISEASE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HUMAN; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REOPERATION; STENT; THERAPY EFFECT; VASCULAR PATENCY; ARTIFICIAL EMBOLISM; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; INSTRUMENTATION; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME;

ANEURYSM; BEHCET SYNDROME; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; EMBOLIZATION, THERAPEUTIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREDNISOLONE; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 71949128149     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/09-2812C.1     Document Type: Note

References (1)

1. Kim WH, Choi D, Kim JS, et al. Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Behçet disease. J Endovasc Ther. 2009;16:631-636.